UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Urotensin II: Better than somatostatin for portal hypertension?

Newby, DE; Jalan, R; (2000) Urotensin II: Better than somatostatin for portal hypertension? HEPATOLOGY , 31 (5) 1201 - 1202.

Full text not available from this repository.

Abstract

Urotensin-II (U-II) is a vasoactive 'somatostatin-like' cyclic peptide which was originally isolated from fish spinal cords, and which has recently been cloned from man. Here we describe the identification of an orphan human G-protein-coupled receptor homologous to rat GPR14 and expressed predominantly in cardiovascular tissue, which functions as a U-II receptor. Goby and human U-II bind to recombinant human GPR14 with high affinity, and the binding is functionally coupled to calcium mobilization. Human U-II is found within both vascular and cardiac tissue (including coronary atheroma) and effectively constricts isolated arteries from non-human primates. The potency of vasoconstriction of U-II is an order of magnitude greater than that of endothelin-1, making human U-II the most potent mammalian vasoconstrictor identified so far. In vivo, human U-II markedly increases total peripheral resistance in anaesthetized non-human primates, a response associated with profound cardiac contractile dysfunction. Furthermore, as U-II immunoreactivity is also found within central nervous system and endocrine tissues, it may have additional activities.

Type:Article
Title:Urotensin II: Better than somatostatin for portal hypertension?
Keywords:ENDOGENOUS LIGAND, ORPHAN RECEPTOR, OCTREOTIDE, CIRRHOSIS, GPR14, IDENTIFICATION

Archive Staff Only: edit this record